• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己糖激酶 2 是有氧糖酵解的关键调节因子,促进了人多形性胶质母细胞瘤的肿瘤生长。

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.

机构信息

The Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children Research Institute, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Exp Med. 2011 Feb 14;208(2):313-26. doi: 10.1084/jem.20101470. Epub 2011 Jan 17.

DOI:10.1084/jem.20101470
PMID:21242296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3039857/
Abstract

Proliferating embryonic and cancer cells preferentially use aerobic glycolysis to support growth, a metabolic alteration commonly referred to as the "Warburg effect." Here, we show that the glycolytic enzyme hexokinase 2 (HK2) is crucial for the Warburg effect in human glioblastoma multiforme (GBM), the most common malignant brain tumor. In contrast to normal brain and low-grade gliomas, which express predominantly HK1, GBMs show increased HK2 expression. HK2 expression correlates with worse overall survival of GBM patients. Depletion of HK2, but neither HK1 nor pyruvate kinase M2, in GBM cells restored oxidative glucose metabolism and increased sensitivity to cell death inducers such as radiation and temozolomide. Intracranial xenografts of HK2-depleted GBM cells showed decreased proliferation and angiogenesis, but increased invasion, as well as diminished expression of hypoxia inducible factor 1α and vascular endothelial growth factor. In contrast, exogenous HK2 expression in GBM cells led to increased proliferation, therapeutic resistance, and intracranial growth. Growth was dependent on both glucose phosphorylation and mitochondrial translocation mediated by AKT signaling, which is often aberrantly activated in GBMs. Collectively, these findings suggest that therapeutic strategies to modulate the Warburg effect, such as targeting of HK2, may interfere with growth and therapeutic sensitivity of some GBMs.

摘要

胚胎和癌细胞优先通过有氧糖酵解来支持生长,这种代谢改变通常被称为“瓦博格效应”。在这里,我们表明,糖酵解酶己糖激酶 2(HK2)对于人类多形性胶质母细胞瘤(GBM)中的瓦博格效应至关重要,GBM 是最常见的恶性脑肿瘤。与表达主要为 HK1 的正常大脑和低级别神经胶质瘤不同,GBM 中 HK2 的表达增加。HK2 的表达与 GBM 患者的总体生存率降低相关。在 GBM 细胞中耗尽 HK2,但不是 HK1 或丙酮酸激酶 M2,可恢复氧化葡萄糖代谢,并增加对辐射和替莫唑胺等细胞死亡诱导剂的敏感性。HK2 耗尽的 GBM 细胞颅内异种移植物显示出增殖和血管生成减少,但侵袭性增加,以及缺氧诱导因子 1α和血管内皮生长因子的表达减少。相比之下,GBM 细胞中外源 HK2 的表达导致增殖、治疗耐药性和颅内生长增加。生长依赖于 AKT 信号转导介导的葡萄糖磷酸化和线粒体易位,AKT 信号转导在 GBM 中经常异常激活。总的来说,这些发现表明,调节瓦博格效应的治疗策略,如靶向 HK2,可能会干扰某些 GBM 的生长和治疗敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/a317dd9620eb/JEM_20101470_RGB_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/b368606085ee/JEM_20101470_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/a32c5fdba657/JEM_20101470_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/7934a2e01179/JEM_20101470_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/77073aa22f1e/JEM_20101470_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/44520fdc979d/JEM_20101470R_RGB_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/a317dd9620eb/JEM_20101470_RGB_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/b368606085ee/JEM_20101470_RGB_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/a32c5fdba657/JEM_20101470_RGB_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/7934a2e01179/JEM_20101470_RGB_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/77073aa22f1e/JEM_20101470_RGB_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/44520fdc979d/JEM_20101470R_RGB_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/3039857/a317dd9620eb/JEM_20101470_RGB_Fig6.jpg

相似文献

1
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme.己糖激酶 2 是有氧糖酵解的关键调节因子,促进了人多形性胶质母细胞瘤的肿瘤生长。
J Exp Med. 2011 Feb 14;208(2):313-26. doi: 10.1084/jem.20101470. Epub 2011 Jan 17.
2
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.正常脑组织和多形性胶质母细胞瘤中糖酵解酶己糖激酶 2 的发育特征和调控。
Neurobiol Dis. 2011 Oct;44(1):84-91. doi: 10.1016/j.nbd.2011.06.007. Epub 2011 Jun 25.
3
Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.靶向己糖激酶2可增强胶质母细胞瘤对放化疗的反应。
Oncotarget. 2016 Oct 25;7(43):69518-69535. doi: 10.18632/oncotarget.11680.
4
HOTAIR/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma.HOTAIR/miR-125 轴介导的己糖激酶 2 表达促进人脑胶质瘤的化疗耐药性。
J Cell Mol Med. 2020 May;24(10):5707-5717. doi: 10.1111/jcmm.15233. Epub 2020 Apr 12.
5
Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.慢病毒介导的HK1、HK2和HK3基因shRNA失活对结直肠癌和黑色素瘤细胞的影响。
BMC Genet. 2016 Dec 22;17(Suppl 3):156. doi: 10.1186/s12863-016-0459-1.
6
Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.阿司匹林影响肿瘤血管生成,并使人类胶质母细胞瘤内皮细胞对替莫唑胺、贝伐单抗和舒尼替尼敏感,损害血管内皮生长因子相关信号传导。
World Neurosurg. 2018 Dec;120:e380-e391. doi: 10.1016/j.wneu.2018.08.080. Epub 2018 Aug 23.
7
miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.miR-542-3p 通过促进 HK2 表达促进人胶质瘤细胞的高糖酵解表型。
Genes (Basel). 2021 Apr 23;12(5):633. doi: 10.3390/genes12050633.
8
Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.EZH2通过miR-181b/HK2轴参与前列腺癌的有氧糖酵解过程。
Oncol Rep. 2017 Mar;37(3):1430-1436. doi: 10.3892/or.2017.5430. Epub 2017 Feb 7.
9
Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration.结直肠癌中的己糖激酶2:一种与糖酵解、增殖和迁移相关的强效预后因素。
Histol Histopathol. 2017 Apr;32(4):351-360. doi: 10.14670/HH-11-799. Epub 2016 Jul 1.
10
Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.TRAP1的下调通过调节代谢重编程使胶质母细胞瘤细胞对替莫唑胺化疗敏感。
Neuroreport. 2016 Feb 10;27(3):136-44. doi: 10.1097/WNR.0000000000000513.

引用本文的文献

1
Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using H MR Spectroscopy and IVIM-DWI.使用氢磁共振波谱和体素内不相干运动扩散加权成像评估胆碱激酶抑制剂与替莫唑胺联合治疗在胶质母细胞瘤小鼠模型中的联合效果。
NMR Biomed. 2025 Sep;38(9):e70113. doi: 10.1002/nbm.70113.
2
The role of mitochondria-associated ER membranes in disease pathology: protein complex and therapeutic targets.线粒体相关内质网膜在疾病病理学中的作用:蛋白质复合物与治疗靶点。
Front Cell Dev Biol. 2025 Jun 30;13:1629568. doi: 10.3389/fcell.2025.1629568. eCollection 2025.
3
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.

本文引用的文献

1
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.整合基因组分析确定了具有 PDGFRA、IDH1、EGFR 和 NF1 异常的胶质母细胞瘤的临床相关亚型。
Cancer Cell. 2010 Jan 19;17(1):98-110. doi: 10.1016/j.ccr.2009.12.020.
2
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.c-Myc 调控的 HnRNP 蛋白使肿瘤中的丙酮酸激酶 mRNA 剪接发生紊乱。
Nature. 2010 Jan 21;463(7279):364-8. doi: 10.1038/nature08697. Epub 2009 Dec 13.
3
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
处于十字路口的胶质母细胞瘤:当前的认识与未来的治疗前景
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4.
4
GLUT1 as a Potential Therapeutic Target in Glioblastoma.葡萄糖转运蛋白1作为胶质母细胞瘤的潜在治疗靶点
Brain Sci. 2025 May 28;15(6):585. doi: 10.3390/brainsci15060585.
5
Glioma stem cells: drivers of tumor progression and recurrence.胶质瘤干细胞:肿瘤进展和复发的驱动因素。
Stem Cell Res Ther. 2025 Jun 7;16(1):293. doi: 10.1186/s13287-025-04352-z.
6
Signaling Pathways in Gliomas.胶质瘤中的信号通路
Genes (Basel). 2025 May 19;16(5):600. doi: 10.3390/genes16050600.
7
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma.利用基于铁死亡的特征来表征多发性骨髓瘤的异质性并优化治疗。
Front Immunol. 2025 Apr 16;16:1559317. doi: 10.3389/fimmu.2025.1559317. eCollection 2025.
8
Inhibiting glycolysis facilitated checkpoint blockade therapy for triple-negative breast cancer.抑制糖酵解促进三阴性乳腺癌的检查点阻断治疗。
Discov Oncol. 2025 Apr 17;16(1):550. doi: 10.1007/s12672-025-02320-w.
9
Navigating Glioma Complexity: The Role of Abnormal Signaling Pathways in Shaping Future Therapies.应对神经胶质瘤的复杂性:异常信号通路在塑造未来治疗方法中的作用。
Biomedicines. 2025 Mar 20;13(3):759. doi: 10.3390/biomedicines13030759.
10
MAM kinases: physiological roles, related diseases, and therapeutic perspectives-a systematic review.MAM激酶:生理作用、相关疾病及治疗前景——一项系统综述
Cell Mol Biol Lett. 2025 Mar 28;30(1):35. doi: 10.1186/s11658-025-00714-w.
癌症相关的 IDH1 突变会产生 2-羟基戊二酸。
Nature. 2009 Dec 10;462(7274):739-44. doi: 10.1038/nature08617.
4
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.AMPK激动剂AICAR通过抑制脂肪生成来抑制表达EGFRvIII的胶质母细胞瘤的生长。
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12932-7. doi: 10.1073/pnas.0906606106. Epub 2009 Jul 22.
5
Understanding the Warburg effect: the metabolic requirements of cell proliferation.理解瓦伯格效应:细胞增殖的代谢需求。
Science. 2009 May 22;324(5930):1029-33. doi: 10.1126/science.1160809.
6
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.IDH1基因中胶质瘤衍生的突变主要抑制IDH1催化活性并诱导缺氧诱导因子-1α(HIF-1α)。
Science. 2009 Apr 10;324(5924):261-5. doi: 10.1126/science.1170944.
7
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.抗血管生成疗法会引发肿瘤的恶性进展,导致局部侵袭增加和远处转移。
Cancer Cell. 2009 Mar 3;15(3):220-31. doi: 10.1016/j.ccr.2009.01.027.
8
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.异柠檬酸脱氢酶1(IDH1)突变是星形细胞瘤和少突胶质细胞瘤发生过程中的早期事件。
Am J Pathol. 2009 Apr;174(4):1149-53. doi: 10.2353/ajpath.2009.080958. Epub 2009 Feb 26.
9
IDH1 and IDH2 mutations in gliomas.胶质瘤中的异柠檬酸脱氢酶1(IDH1)和异柠檬酸脱氢酶2(IDH2)突变
N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.
10
An integrated genomic analysis of human glioblastoma multiforme.多形性胶质母细胞瘤的综合基因组分析
Science. 2008 Sep 26;321(5897):1807-12. doi: 10.1126/science.1164382. Epub 2008 Sep 4.